Medication info
Glithia Soft Capsule (Choline Alphoscerate)

Glithia Soft Capsule (Choline Alphoscerate)

Prescription medicationSoft capsuleOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 capsule
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
A yellow oval soft capsule filled with a colorless and transparent liquid
Packaging
90 capsules (10 capsules/PTP*9)
Approval status
Active

MFDS item code 201405197 · Approved 2014.11.06 · Insurance code 647302910

Summary

Main use
Improvement of organic brain syndrome and symptoms of cerebrovascular deficits (such as memory impairment)
Who takes it
Adults
Adult dose
Administer 400 mg of choline alfoscerate orally 2～3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Improvement of organic brain syndrome and symptoms of cerebrovascular deficits (such as memory impairment)

  • Memory loss
  • confusion
  • decreased will
  • decreased spontaneity
  • disorientation
  • reduced concentration
View approved original text

This medication is used to treat secondary symptoms and degenerative or atrophic organic psychosyndromes resulting from cerebrovascular insufficiency. It helps improve major symptoms such as memory loss, confusion, decreased will and spontaneity, disorientation, and reduced concentration. It is a suitable treatment option for patients whose daily life is difficult due to these symptoms. Clinical trial results have been additionally submitted in South Korea to further confirm its efficacy and safety. Therefore, this medication is helpful in treating mental and cognitive disorders due to impaired brain function.

How to take

Adult dose

Administer 400 mg of choline alfoscerate orally 2～3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication should not be used by patients who have had an allergic reaction to this drug or its components. Women who are pregnant or may become pregnant should not take this medication. Nausea may occur when taking this medication, and if such symptoms appear, the dosage should be reduced. Gastrointestinal problems may occur, potentially leading to gastritis or gastrointestinal disease. It may affect the central nervous system, leading to drowsiness, insomnia, irritability, nervous symptoms, seizures, or excessive activity. This medication should be kept out of reach of children, and it is advisable not to transfer it to another container for safety and quality maintenance.

Side effects

  • nausea
  • gastritis
  • gastric disorders
  • drowsiness
  • insomnia
  • irritability
  • nervousness
  • spasms
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius. This will help preserve the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

A yellow oval soft capsule filled with a colorless and transparent liquid

Package unit

90 capsules (10 capsules/PTP*9)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

See Choline Alfoscerate ingredient details

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.